Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 14.06.2022
Media and Games Invest SE
14/06/2022 - Management interview with Media and Games Invest SE
'We expect to continue to grow in 2022 and to benefit from the market
changes in the media sector. With the additional liquidity from the recent
bond issue, we are also excellently equipped with capital to benefit from
the current market in the M&A area.'
Media and Games Inve [ … ]
Tue, 07.06.2022
Media and Games Invest SE
Q1 2022: MGI continues to grow strongly; Significant earnings increase due
to scale, efficiency and M&A effects; Continuation of dynamic sales growth
expected; GBC estimates and target price confirmed
Business development Q1 2022
Media and Games Invest SE (MGI) published its Q1 business figures on 31 May
2022. According to these figures, t [ … ]
Mon, 30.05.2022
Coreo AG
- Highest investment volume in history
- Active investment strategy continues to be pursued
The past financial year 2021 was marked by the effects of the Corona
pandemic on Coreo AG in the form of more difficult access to properties.
Nevertheless, the company was able to continue its growth strategy with
three acquisitions. Within the framework [ … ]
Wed, 18.05.2022
Saturn Oil & Gas Inc.
Upcoming Investor Event:
Aspermont to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Saturn Oil & Gas will also present its business model and current
business development.
Presentation slot:
Saturn Oil & Gas Inc. (ISIN: CA80412L8832)
01.20 pm [ … ]
Tue, 17.05.2022
EPTI AB
Upcoming Investor Event:
EPTI to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, EPTI AB will also present its business model and current business
development.
Presentation slot:
EPTI AB (ISIN: SE0013774668)
05.20 am EST (New York, Toronto time)
11.20 a [ … ]
Mon, 16.05.2022
Defence Therapeutics Inc.
Upcoming Investor Event:
Defense Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Defense Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Defense Therapeutics Inc. (ISIN: CA24 [ … ]
Sat, 14.05.2022
Cardiol Therapeutics Inc.
Upcoming Investor Event:
Cardiol Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Cardiol Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Cardiol Therapeutics Inc. (ISIN: CA14 [ … ]
Fri, 13.05.2022
Aspermont Ltd.
Upcoming Investor Event:
Aspermont to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Aspermont Ltd. will also present its business model and current
business development.
Presentation slot:
Aspermont Ltd. (ISIN: AU000000ASP3)
04.00 am EST (New York, To [ … ]
Thu, 12.05.2022
CENIT AG
Q1 2022: Revenues slightly up, earnings slightly down year-on-year;
inorganic effects not yet included; we confirm our forecasts; price target
changes due to higher WACC; BUY rating confirmed
The seasonal sales trend of CENIT AG is usually characterised by lower
sales revenues in the first quarter, while the fourth quarter makes the
largest cont [ … ]
Mon, 09.05.2022
Aspermont Ltd.
Q2-2022 preliminary report shows increased growth
The following are some of the company's highlights:
- Total revenue +39% at $4.8m
- Gross profit +43% at $3.1m, with gross margins of 65% versus 63%
- Earnings +20% at $0.5m on a normalized basis
- Dean Felton joined the Aspermont board
- Aspermont returned to live events with Future of [ … ]